Bookmark and Share

Compound Summary for: CID 60854

ziprasidone

Also known as: Geodon; Zeldox; ziprazidone; 146939-27-7; ziprasidona; ziprasidonum; Ziprasidone hydrochloride; Ziprasidone [INN:BAN]
Molecular Formula: C21H21ClN4OS   Molecular Weight: 412.93564   InChIKey: MVWVFYHBGMAFLY-UHFFFAOYSA-N
Ziprasidone (marketed as Geodon, Zeldox) was the fifth atypical antipsychotic to gain FDA approval (February 2001). Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania associated with bipolar disorder. [Wikipedia]   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _